Literature DB >> 10915572

Long-lasting regulation of galanin, opioid, and other peptides in dorsal root ganglia and spinal cord during experimental polyarthritis.

L Calzà1, M Pozza, R Arletti, E Manzini, T Hökfelt.   

Abstract

Mechanisms involved in transition from acute to chronic pain are still not well understood and our means to therapeutically influence this transition are limited. Moreover, very little is known about long-lasting consequences of prolonged exposure to painful stimuli with regard to phenotypic changes and pain experience. In this study we have analyzed long term behavioral and neurochemical effects of intradermal tail injection of heat-killed mycobacterium butyricum suspended in complete Freund's adjuvant. Calcitonin gene-related peptide (CGRP) and galanin mRNA levels were investigated in dorsal root ganglia of polyarthritic rats during the acute (21-) and the remission stage (79 days postinjection), and opioid peptide mRNAs and receptors were studied in the spinal cord. Most of the increases in peptide mRNA levels observed during the acute stage of arthritis were still present in the remission stages. Thus, CGRP and galanin mRNAs in DRGs, and opioid peptide mRNAs and opioid receptors in the spinal cord were still strongly up-regulated, when animals do not exhibit spontaneous pain behavior and inflammation. Hot-plate test in the presence of naloxone, performed in the remission stage, indicated that opiates participate in pain threshold regulation after prolonged painful condition. Finally, X-ray examination revealed a complete destruction of joint structure, thus suggesting a parallel lesion of peripheral nerve endings. These results suggest that in the remission stage of chronic joint inflammation several types of mechanisms are activated aiming at counteracting both inflammatory and neuropathic pain. Thus, opioid systems in the dorsal horn as well as galanin in DRG neurons are upregulated, both alternating pain. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915572     DOI: 10.1006/exnr.2000.7442

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

Review 1.  Ultra-low-level laser therapy.

Authors:  Luigi Baratto; Laura Calzà; Roberto Capra; Michele Gallamini; Luciana Giardino; Alessandro Giuliani; Luca Lorenzini; Silvano Traverso
Journal:  Lasers Med Sci       Date:  2010-09-18       Impact factor: 3.161

Review 2.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Post-conditioning experience with acute or chronic inflammatory pain reduces contextual fear conditioning in the rat.

Authors:  Ian N Johnston; Steven F Maier; Jerry W Rudy; Linda R Watkins
Journal:  Behav Brain Res       Date:  2011-09-06       Impact factor: 3.332

4.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

5.  Targeted disruption of the galanin gene attenuates inflammatory responses in murine skin.

Authors:  Sabine M Schmidhuber; Anna Starr; David Wynick; Barbara Kofler; Susan D Brain
Journal:  J Mol Neurosci       Date:  2007-11-13       Impact factor: 3.444

6.  Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons.

Authors:  P Xu; A K Hall
Journal:  Neuroscience       Date:  2007-09-21       Impact factor: 3.590

7.  Endogenous analgesia, dependence, and latent pain sensitization.

Authors:  Bradley K Taylor; Gregory Corder
Journal:  Curr Top Behav Neurosci       Date:  2014

8.  Activation of extracellular signal-regulated protein kinase 5 is essential for cystitis- and nerve growth factor-induced calcitonin gene-related peptide expression in sensory neurons.

Authors:  Sharon J Yu; Chun-mei Xia; Jarren C Kay; Li-Ya Qiao
Journal:  Mol Pain       Date:  2012-06-28       Impact factor: 3.395

9.  Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.

Authors:  Raphaël Weibel; David Reiss; Laurie Karchewski; Olivier Gardon; Audrey Matifas; Dominique Filliol; Jérôme A J Becker; John N Wood; Brigitte L Kieffer; Claire Gaveriaux-Ruff
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  Lack of Galanin 3 Receptor Aggravates Murine Autoimmune Arthritis.

Authors:  Bálint Botz; Ágnes Kemény; Susanne M Brunner; Felix Sternberg; Janka Csepregi; Attila Mócsai; Erika Pintér; Jason J McDougall; Barbara Kofler; Zsuzsanna Helyes
Journal:  J Mol Neurosci       Date:  2016-03-03       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.